Kelsey Lewis, MD
Urogynecology and Reconstructive Pelvic Surgery · Cincinnati, OHNPI 1568842284
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,699 of the $2,307 with a category attached, or 73.6%. Medtronic accounts for 87.1% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $1,077, more than ten times the $41 reported in 2019. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in OH, where the typical reported total is $3,689.
Across 32 payments — averaging $72.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Axonics, Inc.$118
- Pacira Pharmaceuticals Incorporated$97
- Medical Device Business Services, Inc.$41
- Coloplast$24
- Tactile Systems Technology Inc$18
What the payments were for
- Travel & lodging$60826%
- Food & beverage$1,69974%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 26 | $2,010 |
| Axonics, Inc. | 2 | $118 |
| Pacira Pharmaceuticals Incorporated | 1 | $97 |
| Medical Device Business Services, Inc. | 1 | $41 |
| Coloplast | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,307 in reported general payments places this provider in the 25th percentile of 60 urogynecology and reconstructive pelvic surgery providers in Ohio.
See all urogynecology and reconstructive pelvic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 26 | $14,991 |
| GemtesaVibegron | 20 | $13,303 |
| Methenamine Hippurate | 37 | $2,040 |
| Estradiol | 28 | $1,251 |
| Solifenacin Succinate | 16 | $671 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Cincinnati
- Anne StachowiczCincinnati$10K
- Anna ZdroikCincinnati$8K
- Jennifer YeungCincinnati$7K
- Catrina CrispCincinnati$3K
- Steven KleemanCincinnati$820
- Aparna ShahCincinnati$753
- Costas ApostolisStrongsville$982K
- Mickey KarramWest Chester$127K
- Sangeeta MahajanMayfield Hts$48K
- Emily SlopnickCleveland$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.